ConductScience.org, home

Paper39680334

Impact of statin therapy on CD40:CD40L signaling: mechanistic insights and therapeutic opportunities.

Askarizadeh F and 3 others. Pharmacol Rep, 2025. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. Impact of statin therapy on CD40:CD40L signaling: mechanistic insights and therapeutic opportunities. Papers, record 39680334. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39680334

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Impact of statin therapy on CD40:CD40L signaling: mechanistic insights and therapeutic opportunities.
PubMed
Journal
Pharmacol Rep
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
2.87, provisional
iCite
Revised in PubMed
2025-05-18
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Askarizadeh FFatemeh
2Karav SSercan
3Jamialahmadi TTannaz
4Sahebkar AAmirhosseinhttps://orcid.org/0000-0002-8656-1444

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hydroxymethylglutaryl-CoA Reductase InhibitorsMajor topic
CD40 AntigensMajor topic
CD40 LigandMajor topic
Anti-Inflammatory AgentsMajor topic
Humans
Signal Transduction
Animals
Inflammation
Cardiovascular Diseases
Autoimmune Diseases

Source PubMed

Download CSV of topics

References294

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115089818Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes.Br J Clin Pharmacol2004https://conductscience.org/library/papers/15089818PubMed
215993711Statins affect cell-surface expression of major histocompatibility complex class II molecules by disrupting cholesterol-containing microdomains.Hum Immunol2005https://conductscience.org/library/papers/15993711PubMed
317482516Action profiles of statins and calcineurin inhibitors during human mixed lymphocyte reaction.Clin Immunol2007https://conductscience.org/library/papers/17482516PubMed
416387846Differential effects of statins on relevant functions of human monocyte-derived dendritic cells.J Leukoc Biol2006https://conductscience.org/library/papers/16387846PubMed
525970700A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations.Sci Rep2015https://conductscience.org/library/papers/25970700PubMed
637732056The effects of statins on the function and differentiation of blood cells.Arch Med Sci2023https://conductscience.org/library/papers/37732056PubMed
733656763The role of statins in the differentiation and function of bone cells.Eur J Clin Invest2021https://conductscience.org/library/papers/33656763PubMed
827498397Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms.Atherosclerosis2016https://conductscience.org/library/papers/27498397PubMed
933511728Effects of statins on mitochondrial pathways.J Cachexia Sarcopenia Muscle2021https://conductscience.org/library/papers/33511728PubMed
1026632869The impact of statin therapy on plasma levels of von Willebrand factor antigen. Systematic review and meta-analysis of randomised placebo-controlled trials.Thromb Haemost2016https://conductscience.org/library/papers/26632869PubMed
1121207250Simvastatin therapy reduces prooxidant-antioxidant balance: results of a placebo-controlled cross-over trial.Lipids2011https://conductscience.org/library/papers/21207250PubMed
1226017749Association between statin use and plasma D-dimer levels. A systematic review and meta-analysis of randomised controlled trials.Thromb Haemost2015https://conductscience.org/library/papers/26017749PubMed
1314499877Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells.Cardiovasc Res2003https://conductscience.org/library/papers/14499877PubMed
1423017371Statins and other agents for vascular inflammation.J Vasc Surg2012https://conductscience.org/library/papers/23017371PubMed
1511701455Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.Arterioscler Thromb Vasc Biol2001https://conductscience.org/library/papers/11701455PubMed
1611100127Statins as a newly recognized type of immunomodulator.Nat Med2000https://conductscience.org/library/papers/11100127PubMed
1730120976Effect of statins on toll-like receptors: a new insight to pleiotropic effects.Pharmacol Res2018https://conductscience.org/library/papers/30120976PubMed
1827010807The "Rise-Peak-Fall" Pattern of Time Dependency of the Cardiovascular Pleiotropic Effects of Treatment With Low-dose Atorvastatin, Losartan, and a Combination Thereof in Rats.J Cardiovasc Pharmacol2016https://conductscience.org/library/papers/27010807PubMed
1915173059Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?Circulation2004https://conductscience.org/library/papers/15173059PubMed
2027120457Rosuvastatin Attenuates CD40L-Induced Downregulation of Extracellular Matrix Production in Human Aortic Smooth Muscle Cells via TRAF6-JNK-NF-κB Pathway.PLoS One2016https://conductscience.org/library/papers/27120457PubMed

See all 294 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
41676279The role of CD40/CD40L signaling in vascular inflammation and aneurysm progression: a systematic review and evidence synthesis.Am J Transl Res2026https://conductscience.org/library/papers/41676279PubMed
41231308Statins as Modulators of Epithelial to Mesenchymal Transition in Cardiovascular-Kidney-Metabolic Syndrome: a Comprehensive Review of Mechanisms and Therapeutic Implications.Curr Atheroscler Rep2025https://conductscience.org/library/papers/41231308PubMed
41114911Integrative multi-omics and causal inference reveal periodontal ligament cell-macrophage crosstalk under orthodontic force.Prog Orthod2025https://conductscience.org/library/papers/41114911PubMed
41042403Overlapping risk factors and pathogenic mechanisms in lung cancer and cardiovascular disease.Discov Oncol2025https://conductscience.org/library/papers/41042403PubMed
41002646Sjogren's Disease and Elevated Cardiovascular Risk: Mechanisms and Treatment.J Cardiovasc Dev Dis2025https://conductscience.org/library/papers/41002646PubMed
40427505Understanding the Role of Adipokines in Cardiometabolic Dysfunction: A Review of Current Knowledge.Biomolecules2025https://conductscience.org/library/papers/40427505PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD40958PubTator's text mininghttps://conductscience.org/library/genes/958NCBI Gene
CD40LG959PubTator's text mininghttps://conductscience.org/library/genes/959NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39680334

GET https://conductscience.org/api/papers/v1/39680334/references?page=2